Table 1. Clinical characteristics of patients with bilateral breast cancer and metastatic breast cancer.
Patient ID | Tumor 1 | Tumor 2 | Diagnosis | ||||||
---|---|---|---|---|---|---|---|---|---|
Age (years) | Anatomical site | Subtype | TNM stage | Time since cancer 1 | Anatomical site | Subtype/histologic type | TNM stage | ||
1 | 55 | Breast | Luminal | T2N0M0 | 1 month | Contralateral breast | Luminal | T3N0M0 | Synchronous BBC |
2 | 55 | Breast | HER2-enriched | T2N1Mx | 1 month | Contralateral breast | Luminal | T1N0Mx | Synchronous BBC |
3 | 45 | Breast | Basal-like | T3N0M0 | 2 years | Contralateral breast | Basal-like | T1N0Mx | Metachronous BBC |
4 | 46 | Breast | HER2-enriched | T2N1M0 | 3 years | Contralateral breast | Basal-like | T2N0Mx | Metachronous BBC |
5 | 41 | Breast | Basal-like | T3N1M0 | 4 years | Liver | Mucinous adenocarcinoma | / | Metastatic breast cancer |
6 | 49 | Breast | HER2-enriched | T2N2M0 | 6 months | Liver | Adenocarcinoma | / | Metastatic breast cancer |
BBC, bilateral breast cancer.